Skip to main content
Fig. 1 | Nutrition Journal

Fig. 1

From: Patients’ perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe? – a patient survey

Fig. 1

Coffee consumption in 442 IBD patients. Almost three quarters of patients (72.6 %) regularly consume coffee (93.5 % caffeinated coffee, 6.5 % decaffeinated coffee). This distribution appears very similar in CD, UC and IBDU (209 of 288, 72.6 % of CD, 107 of 147, 72.8 % of UC and 5 of 7, 71.4 % of IBDU patients; IBD: Inflammatory bowel disease, CD: Crohn’s disease, UC: ulcerative colitis, IBDU: IBD unclassified)

Back to article page

Nutrition Journal

ISSN: 1475-2891

Contact us